Zobrazeno 1 - 10
of 24
pro vyhledávání: '"S. Reiseter"'
Autor:
G. Boleto, S. Reiseter, A. M. Hoffmann-Vold, A. Mirouse, P. Cacoub, M. Matucci-Cerinic, M. Silvério-António, J. E. Fonseca, V. Riccieri, E. Le Tallec, A. Lescoat, J. L. Tandaipan, I. Castellví, P. Airò, M. Kuwana, H. Kavosi, J. Avouac, Y. Allanore
Publikováno v:
Annals of the Rheumatic Diseases. 81:249.1-250
BackgroundMixed connective tissue disease (MCTD) is a rare autoimmune condition characterized by Raynaud’s phenomenon, positivity of autoantibodies targeting the U1 small nuclear ribonucleoprotein particle (U1RNP), and various clinical features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b94f4d251ac553db001a6efb8e17fad2
https://doi.org/10.1136/annrheumdis-2022-eular.1351
https://doi.org/10.1136/annrheumdis-2022-eular.1351
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ragnar Gunnarsson, Helena Andersson, S. Reiseter, Anna-Maria Hoffmann-Vold, I. Barua, Håvard Fretheim, Øyvind Midtvedt, Øyvind Molberg, Trond Mogens Aaløkken, Michael T. Durheim, Torhild Garen
Publikováno v:
Annals of the Rheumatic Diseases. 80:104.2-105
Background:Based on the argument that symptoms define disease, physicians commonly apply the terms “preclinical” or “subclinical” disease to describe patients with disease-related findings but no accompanying symptoms for connective tissue di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b871c40702ed531e893e603c5068b0be
https://doi.org/10.1136/annrheumdis-2021-eular.3810
https://doi.org/10.1136/annrheumdis-2021-eular.3810
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charles J. Cohen, Margaret Z Chou, Brande S. Williams, Yui S. Tang, Ivy E. Dick, Brita S. Reiseter, Maria L. Garcia, Gregory J. Kaczorowski, Keith A. Wafford, William J. Martin, Samantha Clark, Vivien A. Warren, Peter T. Meinke, Ge Dai, William H. Parsons, Richard E. Middleton, William A. Schmalhofer, Martin Köhler, McHardy M. Smith, Richard M. Brochu, Shao Pengcheng Patrick, Chou J. Liu, Birgit T. Priest, John P. Felix
Publikováno v:
Biochemistry. 43:9866-9876
Sodium channel blockers are used clinically to treat a number of neuropathic pain conditions, but more potent and selective agents should improve on the therapeutic index of currently used drugs. In a high-throughput functional assay, a novel sodium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3ddd47eae5772bd4e88e362138fc4d
https://doi.org/10.1021/bi0493259
https://doi.org/10.1021/bi0493259
Autor:
James R. Tonra, Robbie Robertson, Ronald M. Lindsay, Brita S. Reiseter, Bruce Keyt, Roland Kolbeck, Kumiko Nagashima
Publikováno v:
The Journal of Comparative Neurology. 430:131-144
Experimental autoimmune encephalomyelitis (EAE) is an animal model for human multiple sclerosis (MS). Similar to MS patients, EAE animals can exhibit chronic or relapsing, remitting paralysis; leukocyte infiltration of the central nervous system (CNS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da11239af525aca163a995dd11488931
https://doi.org/10.1002/1096-9861(20010129)430:1<131::aid-cne1019>3.0.co
https://doi.org/10.1002/1096-9861(20010129)430:1<131::aid-cne1019>3.0.co
Publikováno v:
The Journal of comparative neurology. 430(1)
Experimental autoimmune encephalomyelitis (EAE) is an animal model for human multiple sclerosis (MS). Similar to MS patients, EAE animals can exhibit chronic or relapsing, remitting paralysis; leukocyte infiltration of the central nervous system (CNS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::13ed7fdb0ff0b53050ecce9c38a6c391
https://pubmed.ncbi.nlm.nih.gov/11135250
https://pubmed.ncbi.nlm.nih.gov/11135250
Publikováno v:
Clinical immunology (Orlando, Fla.). 95(2)
The treatment of autoimmune diseases by targeted down-regulation of autoantigen-specific cells has been accomplished by the administration of high doses of autoantigen. We performed direct comparisons between injection of myelin basic protein peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51731a6a1564c9fddf0aac67602a207d
https://pubmed.ncbi.nlm.nih.gov/10779404
https://pubmed.ncbi.nlm.nih.gov/10779404
Publikováno v:
Journal of neuroimmunology. 91(1-2)
Experimental autoimmune encephalomyelitis (EAE) can be effectively treated during disease exacerbation by administration of a peptide corresponding to the major T cell epitope of myelin basic protein (MBP), but the mechanism by which T cell tolerance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321d3b59f49d6bb121ebe5d4b0b38178
https://pubmed.ncbi.nlm.nih.gov/9846832
https://pubmed.ncbi.nlm.nih.gov/9846832
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.